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Study objectives: To test if morbid obesity causes pulmonary function changes and
if massive weight loss have effect on pulmonary function (especially in subjects with
BMIX60 kg/m2).
Participants: Thirty-nine morbid obese subjects before and after massive weight
loss.
Measurements and results: Patients had baseline BMIX40 kg/m2, pulmonary
function test (PFT) before and after surgery for gastric volume reduction and
massive weight loss, and presented no complaints unrelated to obesity. Based on
initial BMI, the patients were dividied in groups A (BMI 40–59.9 kg/m2) and B
(BMIX60 kg/m2). Initially, group A (n ¼ 28) had normal PFT, however group B
(n ¼ 11) presented FVC and FEV1 measurements in the lowest limit of normality
(with normal FEV1/FVC), significantly different from group A. After massive weight
loss, the group B compared to A had a significant improvement in FVC (23.7% vs.
9.7%, P ¼ 0:012) and FEV1 (25.6% vs. 9.1%, P ¼ 0:006); thus the initial difference in
FVC and FEV1 between groups no longer existed after weight loss.
Conclusions: These results point out that the severe morbid obesity (BMIX60 kg/m2)
may lead to pulmonary function impairment and presents more prominent
pulmonary function gain after massive weight reduction. The possible clinical
implications of these results are that PFT abnormalities in subjects with BMIo60 kg/
m2 should probably be interpreted as consequence of intrinsic respiratory disease
and that severe morbid obese patients may be encouraged to lose weight to improve
their pulmonary function, especially those with concomitant pulmonary disorders.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Weight loss and pulmonary function 1101Introduction
Obesity is becoming more and more prevalent
worldwide and can be defined by the presence of
body mass index (BMI) 430 kg/m2. In Brazil, there
also is a trend of increasing prevalence, from 2.1%
to 12.4% (1975–1997).1,2 This increase in the
prevalence turns obesity into one of the most
common disorders in medical practice, associated
with a large number of other clinical conditions or
diseases, such as cardiovascular disorders, diabetes
mellitus, chronic arterial hypertension, hyperlipi-
demia, digestive diseases, sleep apnea, asthma and
pulmonary function changes.3–6
The influence of weight loss on different organ
functions has been studied in malnourished, criti-
cally ill and obese subjects. Specifically in obese
patients, weight reduction may improve diastolic
cardiac function and affect the entire cluster of
cardiovascular disease (CVD) risk factors, such as
insulin resistance and type 2 diabetes mellitus,
dyslipidemia, hypertension and inflammation.7–9
Therefore, weight-management strategies should
be considered as primary therapy for obese
patients with CVD.7
Regarding changes in pulmonary function related
to morbid obesity, it has been described a
consequent decrease in functional residual capa-
city (FRC) and expiratory reserve volume (ERV).
Although some studies have addressed the question
about the impact of massive weight reduction on
respiratory function of patients with morbid obesity
(BMI440 kg/m2), this has never been specifically
addressed in severe morbid obesity (BMIX60 kg/
m2).10–13 The aim of this study was to analyse the
pulmonary function patterns related to morbid
obesity, and the effect of massive weight loss on
pulmonary function testing (PFT), emphasizing on
subjects with BMI X60 kg/m2.Methods
Selection of Subjects
Morbid obese patients from the Endocrinology
Division of our terciary hospital in Sa˜o Paulo, Brazil
that underwent surgery for gastric volume reduc-
tion (bariatric surgery) from 2000 to 2002, were
studied retrospectively by their medical records,
performing a total of 99 subjects. Thirty-nine of
these patients had pulmonary fuction testing (PFT)
before and after the surgery. They were stratified
according to their BMI prior to surgery into group A
(morbid obese—BMI 40–59.9 kg/m2) and B (severemorbid obese—BMIX60 kg/m2). The BMI was com-
puted as the ratio between body weight (kg) and
squared height (m). Clinical data and smoking
history were achieved from medical records and
demographic data concerning age, sex, weight and
height were obtained from PFT datasheet. Height
and weight, as standard of PFT lab, were measured
in the standing position, with subjects wearing soft
clothes, without shoes.Pulmonary function testing
PFT was performed with the patient in sitting
position, with nose clips in place, using a flow
sensor pneumotachograph (Pulmonary Data Servi-
ce—Koko—Colorado, USA). Patients performed 3
acceptable FVC maneuvers according to American
Thoracic Society guidelines, meeting repeatability
criteria.14 The largest FVC and FEV1 values were
reported, regardless of the maneuver. FEV1/FVC
ratio was also calculated.Statistical analysis
All statistical analysis was done using SPSS statis-
tical package program (SPSS Inc., Chicago, IL, USA).
Data are expressed as mean7SD, and statistical
significance was set at P o0.05. We tested normal
distribution of the data within the groups with
Kolmogorov–Smirnov test, and then we used un-
paired t-test for the comparison between groups.
Pearson correlation coefficients were calculated to
describe the relationship between BMI and baseline
FVC, and between BMI reduction and absolute
changes in FVC and FEV1 in the entire group
(n ¼ 39). We also calculated the effect of weight
loss and BMI reduction, through linear regression
models, on absolute changes in FVC and FEV1 and
on relative changes in FVC and FEV1 (calculated by
the ratio of post-surgery minus baseline value over
baseline; values in liters).Results
Thirty-nine patients were enrolled and divided into
groups A (BMI 40–59.9 kg/m2) and B (BMIX60 kg/
m2). The group A had 28 patients (25 women) and
group B had 11 subjects (7 women). The baseline
demographic and PFTcharacteristics are outlined in
Table 1. We found a significant correlation between
baseline FVC and BMI (r ¼ 0:35; P ¼ 0:02) (Fig. 1).
The proportion of smokers and/or ex-smokers
was 39% in group A and 45% in group B, without any
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Table 1 Baseline demographic and spirometric characteristics.
All Group A Group B
Age 37.977.8 39.177.9 34.977.3
Height 1.6178 1.6176.6 152711.1
Weight 137.5730.3 122.4716.8 175.9721.8*
BMI 52.5710.5 47.176.4 66.274.9*
FVC% 93.1714.9 97.9711.5 80.9716.1*
FEV1% 92.5717 97.2714 80.5718.5*
FEV1/FVC 0.83 0.83 0.84
Group A: BMI 40–59.9 kg/m2. Group B: BMI X60 kg/m2.
Data presented as mean7SD.
*Po0.05 for the comparison between groups A and B.
BMI: body mass index.
FVC%: FVC in percent of the predicted.
FEV1%: FEV1 in percent of the predicted.
Figure 1 Correlation between baseline FVC and BMI
(r ¼ 0:35; P ¼ 0:02).
A.N.C. Santana et al.1102clinical complain suggestive of obstructive disease.
There was no change in smoking habit after surgery.
Data after massive weight loss are shown in Table
2 for the entire population and for groups A and B.
The mean time between surgery and post-operative
PFTwas of 1274 months with a mean weight loss of
35.879.1% of their initial weight, without differ-
ence between groups (P ¼ 0:749). For the entire
population (n ¼ 39), there was a significant corre-
lation between absolute weight loss and absolute
changes in FVC (r ¼ 0:526, P ¼ 0:001) and in FEV1
(r ¼ 0:568, Po0.001). These correlations were
maintained between absolute change in BMI and
absolute changes in FVC (r ¼ 0:414, P ¼ 0:009) and
FEV1 (r ¼ 0:433, P ¼ 0:006), and also between
absolute change in BMI and relative changes in
FVC and FEV1 (Figs. 2 and 3). Based on these
findings, for every change of 10 kg/m2 in BMI, the
FVC improved by 150mL, and the FEV1 by 105mL.We found a significant difference between the
two groups when considering the changes in FVC
and FEV1 after weight loss. While FVC and FEV1
increased, respectively, 0.301 (9.7%) and 0.229 L
(9.1%) in group A, group B presented a marked
increase of 0.632L (23.7%) in FVC (P ¼ 0:012) and of
0.556 L (25.6%) in FEV1 (P ¼ 0:006). Because of this
marked gain in pulmonary function presented in the
group B, the initial, statistically significant differ-
ence in FVC and FEV1 between groups A and B
disappeared after weight loss (P ¼ 0:078 and 0:156,
respectively).Discussion
The major finding of the present study was
that severe morbid obese subjects presented
a marked and significantly higher gain in FVC
and in FEV1 despite the same degree of relative
weight loss than morbid obese patients with lower
BMI.
Obesity may induce restrictive disturbance of
respiratory function, related to reduced compli-
ance of chest wall and/or pulmonary parenchyma.
The chest mechanics in morbid obese are altered
due to the subcutaneous adipose tissue and the
splinting of diaphragm by intraabdominal fat, and
the decreased lung compliance has been related to
increased pulmonary blood volume.4 In our study, in
agreement with data previously published, severe
morbid obese subjects (group B) with no complaints
other than obesity initially had FVC and FEV1 in
the lowest limits of normality, with normal FEV1/
FVC.4,15 In contrast, group A had normal values of
FVC, FEV1 and FEV1/FVC at baseline, suggesting
that the impairment at pulmonary function can
be associated only to severe morbid obesity.
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Table 2 Post-surgery data.
All Group A Group B
Percentual weight loss 35.879.1% 35.578.7% 36.6710.4%
FVC% 105.4713.1 107.7713.4 99.5710.8
Relative change FVC (%) 13.6716.1 9.7714 23.7717.2*
FEV1% 104.4713 106.3713.2 99.6711.8
Relative change FEV1 (%) 13.8717.4 9.1713.4 25.6721.3*
FEV1/FVC 0.83 0.83 0.84
Data presented as mean7SD.
*Po0.05 for the comparison between groups A and B.FVC%: FVC in percent of the predicted.
Relative change FVC: (post-surgery FVC–initial FVC) /initial FVC.
FEV1%: FEV1 in percent of the predicted.
Relative change FEV1: (post-surgery FEV1initial FEV1)/initial FEV1.
Figure 2 Correlation between relative change in FVC
(post-surgeryinitial FVC/initial FVC, presented in per-
centual) and absolute change in BMI (r ¼ 0:509;
P ¼ 0:001).
Figure 3 Correlation between relative change in FEV1
(post-surgeryinitial FEV1/initial FEV1, presented in
percentual) and absolute change in BMI (r ¼ 0:513;
P ¼ 0:001).
Weight loss and pulmonary function 1103Consequently, in subjects with BMIo60 kg/m2, the
finding of abnormal FVC and/or FEV1 should not
prevent the investigation of other clinical situa-
tions that lead to lung function abnormalities, such
as pulmonary or chest wall diseases.
Considering PFT changes related to weight
reduction, there was a significant correlation
between absolute weight loss and absolute changes
in FVC. Between groups A and B, the relative
change in FVC and FEV1 were significantly different
for the same degree of relative weight loss (735%).
In addition, after massive weight reduction, the
significant difference of FVC and FEV1 between
groups A and B, which initially existed, disap-
peared. These findings reinforce the data pre-
viously described that respiratory function decline
related to weight gain is worse among subjects with
higher baseline BMI.16,17A limitation of this study might be the selection
of morbid obese subjects. We selected only those
with complete data and PFT before and after
bariatric surgery (39 from 99). Furthermore,
measurements of total lung capacity and residual
volume as well as other clinical variables like
oxygen saturation or arterial blood gases, which
would greatly improve the physiological under-
standing about the effects of weight loss in
respiratory function, were not available for our
analysis. However, pulmonary function reports did
not mention any abnormality in oxygen saturation
at baseline nor after weight loss. Nevertheless, the
initial PFT measurements in groups A and B were in
accordance with previously published data invol-
ving patients with BMI of 40–59.9 kg/m2 and
X60 kg/m2, respectively.4,10,15,18 Even though, a
prospective study following these populations
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clarify the impact of these changes over daily
activities and quality of life of morbid obese
patients, mainly in subjects with BMIX60 kg/m2.
Previous data have shown that weight loss might
have a positive repercussion in pulmonary function
and even in respiratory symptoms of morbid obese
patients.19,20 Specifically in asthmatic, weight loss
was related to decreases variability in peak flow
during the day.20 None of the studies, however,
included patients with BMI greater than 60 kg/m2.
This population, according to our results, is of
particular interest once, even without respiratory
complains, pulmonary function is presented at the
lowest limits of normality and completely normal-
ized after massive weight loss.
In conclusion, the results presented here point
out that the severe morbid obesity (BMIX60 kg/m2)
may lead to pulmonary function impairment with
all its potential complications. Furthermore, the
severe morbid obese subjects had more prominent
pulmonary function gain related to weight reduc-
tion. The possible clinical implications of these
results are that PFT abnormalities in subjects with
BMIo60 kg/m2 should be properly investigated and
not immediately interpreted as consequence of
respiratory impairment related to obesity, and that
severe morbid obese patients should be encouraged
to lose weight to improve their pulmonary function,
what could probably have especial importance for
those with concomitant pulmonary disorders.References
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